Search
MDxHealth SA
MDXHAdd to Watchlist
0.147USD
+0.008+5.76%
Close 11-11 16:00（ET）
4.01MMarket Cap
LossP/E TTM
MDxHealth SA (MDXH) Stock Price Target & Forecast
Analyst Rating
Based on 6 analysts giving stock ratings to MDxHealth SA in the past month.
Hold
1 Strong Buy
3 Buy
2 Hold
0 Sell
0 Strong Sell
Target Price
1.125USD+588.92%
MDXH Analyst Recommendation Trends
In the current month, MDXH has received 3 Buy Ratings, 2 Hold Ratings, and 0 Sell Ratings. MDXH average Analyst price target in the last month is 1.125.
2026-11
2026-10
2026-09
2026-08
2026-07
2026-06
2026-05
2026-04
1
1
1
1
2
3
3
3
3
3
3
3
3
3
3
3
2
2
2
2
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6
6
6
6
6
6
6
6
MDXH Analyst Rating for Peer Comparison
Updated: Nov 5, 2026Company name
Strong Buy
Buy
Hold
Sell
Strong Sell
Analysts
argenx SE
ARGX
10
14
3
0
0
27
Beigene Ltd
ONC
8
19
0
0
0
27
Ionis Pharmaceuticals Inc
IONS
6
16
4
0
0
26
Insmed Inc
INSM
6
18
1
0
0
25
Revolution Medicines Inc
RVMD
10
14
1
0
0
25
Ascendis Pharma A/S
ASND
9
13
1
0
0
23
CRISPR Therapeutics AG
CRSP
4
8
11
0
0
23
Kymera Therapeutics Inc
KYMR
9
12
2
0
0
23
Tempus AI Inc
TEM
4
7
11
0
1
23
Biontech SE
BNTX
4
12
6
0
0
22
Financial Forecasting
Based on analysts' estimates, MDXH EPS is projected to reach -0.092 in FY2026Q3, following reported EPS of -0.220 in FY2026Q2. Track earnings expectations against reported figures to see how profitability is evolving.
EPS
Revenue
Net Profit
EBIT
Forecast
Actual
FY2025Q4
FY2026Q1
FY2026Q2
FY2026Q3
FY2026Q4
Forecast
-0.13
-0.15
-0.19
-0.09
-0.08
Actual
-0.17
-0.17
-0.22
--
--
Surprise
-35.47%
-11.84%
-13.40%
--
--
FAQs
What is MDxHealth SA's expected revenue for the next quarter?
MDxHealth SA's expected revenue is 30.78M.
What is MDxHealth SA's price target?
Analysts forecast that MDxHealth SA's price target is USD 1.12, with the highest forecast at USD 2.00 and the lowest forecast at USD 0.50.
How have MDxHealth SAMDXH's recent earnings per share performed?
The market expectation was USD -0.22, while MDxHealth SAMDXH's earnings per share (EPS) for the previous quarter was USD -0.17. EPS for the next quarter is expected at USD -0.09.
What is the analyst rating for MDxHealth SA?
Based on the ratings of MDxHealth SA's stock from 6 analysts, most analysts support a signal_hold trend. After considering the opinions of other analysts, we ultimately rate Apple's stock as signal_hold. Please note that this is not trading advice. You still need to conduct your own analysis.